Packages (Simulation)
Reagent Preparation
Image (I)
Image (II)
Certificate
Multiplex Assay Kit for Urotensin 2 (UST2) ,etc. by CBA (Cytometric Bead Array)
UII; U-II; UCN2; PRO1068; Urotensin-II
- Product No.CMA362Mu
- Organism SpeciesMus musculus (Mouse) Same name, Different species.
- Sample Typeserum, plasma and other biological fluids
- Test MethodCompetitive Inhibition
- Assay Length3h
- Detection Range0.4883-500pg/mL
- SensitivityThe minimum detectable dose of this kit is typically less than 0.1628pg/mL.
- DownloadInstruction Manual
- UOM 48T96T
- FOB
US$ 545
US$ 778
For more details, please contact local distributors!
Specificity
This assay has high sensitivity and excellent specificity for detection of Urotensin 2 (UST2) ,etc. by CBA (Cytometric Bead Array).
No significant cross-reactivity or interference between Urotensin 2 (UST2) ,etc. by CBA (Cytometric Bead Array) and analogues was observed.
Recovery
Matrices listed below were spiked with certain level of recombinant Urotensin 2 (UST2) ,etc. by CBA (Cytometric Bead Array) and the recovery rates were calculated by comparing the measured value to the expected amount of Urotensin 2 (UST2) ,etc. by CBA (Cytometric Bead Array) in samples.
| Matrix | Recovery range (%) | Average(%) |
| serum(n=5) | 91-104 | 101 |
| EDTA plasma(n=5) | 80-102 | 83 |
| heparin plasma(n=5) | 99-105 | 102 |
Precision
Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Urotensin 2 (UST2) ,etc. by CBA (Cytometric Bead Array) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Urotensin 2 (UST2) ,etc. by CBA (Cytometric Bead Array) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%
Linearity
The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Urotensin 2 (UST2) ,etc. by CBA (Cytometric Bead Array) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.
| Sample | 1:2 | 1:4 | 1:8 | 1:16 |
| serum(n=5) | 78-95% | 80-95% | 80-96% | 82-103% |
| EDTA plasma(n=5) | 92-101% | 97-105% | 91-105% | 89-105% |
| heparin plasma(n=5) | 80-101% | 85-95% | 80-104% | 78-99% |
Stability
The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.
Reagents and materials provided
| Reagents | Quantity | Reagents | Quantity |
Assay procedure summary
1. Add 200μL analysis buffer solution to each well of the plate for pre-wetting;
2. Preparation of standards, reagents and samples before the experiment;
3. Add 100μL standard or sample to each well, add 10μL magnetic beads, and incubate 120 minutes protect from light at 25°C on shaker;
4. Remove liquid on magnetic frame, add 100μL prepared Detection Reagent A. Incubate 60 minutes protect from light at 25°C on shaker;
5. Remove liquid on magnetic frame, add 100μL prepared Detection Reagent B, and incubate 30 minutes protect from light at 25°C on shaker;
6. Wash plate once on magnetic frame;
7. Add 100μL sheath fluid, swirl for 10 minutes, read on the machine.
GIVEAWAYS
INCREMENT SERVICES
| Magazine | Citations |
| Clinical and Experimental Hypertension | Serum Urotensin II Levels in Patients with Non-Dipper Hypertension Pubmed: 23301552 |
| Peptides | Urotensin II (U-II), a novel cyclic peptide, possibly associated with the pathophysiology of osteoarthritis Pubmed: 24468547 |
| journal of diabetes and its complications | Urotensin-II level and its association with oxidative stress in early diabetic nephropathy. pubmed:25179234 |
| Evidence-based Complementary and Alternative Medicine | Acute Biochemical, Cardiovascular, and Autonomic Response to Hyperbaric (4 atm) Exposure in Healthy Subjects Pubmed:29977313 |
| JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS | The Relationship of the Urotensin-2 Level in the Aqueous Humor with Systemic Diseases and Pupil Size: Comparative Study Pubmed: 33147089 |
| Boy kısalığı olan çocukların serum ürotensin 2 düzeylerinin igf-1 ile ilişkisi. |
| Catalog No. | Related products for research use of Mus musculus (Mouse) Organism species | Applications (RESEARCH USE ONLY!) |
| RPA362Mu01 | Recombinant Urotensin 2 (UST2) | Positive Control; Immunogen; SDS-PAGE; WB. |
| RPA362Mu02 | Recombinant Urotensin 2 (UST2) | Positive Control; Immunogen; SDS-PAGE; WB. |
| PAA362Mu01 | Polyclonal Antibody to Urotensin 2 (UST2) | WB; IHC; ICC; IP. |
| PAA362Mu02 | Polyclonal Antibody to Urotensin 2 (UST2) | WB; IHC; ICC; IP. |
| CEA362Mu | ELISA Kit for Urotensin 2 (UST2) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| CMA362Mu | Multiplex Assay Kit for Urotensin 2 (UST2) ,etc. by CBA (Cytometric Bead Array) | FLIA Kit for Antigen Detection. |
| LMA362Mu | Multiplex Assay Kit for Urotensin 2 (UST2) ,etc. by FLIA (Flow Luminescence Immunoassay) | FLIA Kit for Antigen Detection. |

